Consumer protection
No progress without caution.
Retatrutide is a potent molecule in advanced clinical trials. Before considering it, know the clinical-study access pathway and the risks.
Access through clinical studies
Retatrutide is not yet approved as a finished pharmaceutical in Thailand. Safe access is only available through approved clinical study programs such as our partner clinic's program under the Thai FDA / ethics committee. Independent sale or import outside an approved study program is not the intended route.
Caution: not every source is verified
Retatrutide peptides sold online are often labeled 'for research use only'. They are not part of an approved study program and therefore not vetted under pharmaceutical law. Purity, dosage and sterility are unknown. Common issues: endotoxin contamination, incorrect sequences, bacterial contamination — with potentially severe health consequences.
Medical supervision is mandatory
All compounds in this class raise heart rate, affect blood glucose and can trigger gastrointestinal side effects. Blood pressure, pulse, pancreatic enzymes and kidney function must be monitored regularly — only by a qualified medical professional.
What you can do
- Check your eligibility for our partner clinic's approved clinical study program.
- Use approved alternatives (Semaglutide, Tirzepatide) under medical supervision.
- Explicitly avoid unverified online products.
Getting Retatrutide?
How do I get Retatrutide?
Short answer: Retatrutide is not an over-the-counter finished pharmaceutical. Safe access is only possible through approved clinical study programs, such as our partner clinic's. What you should know:
Clinical study access
Retatrutide is still in the regulatory approval phase as a finished pharmaceutical in the EU and US. It can, however, be provided within approved clinical studies — including our partner clinic's — for eligible participants.
Not every source is equal
Offers on peptide sites often label Retatrutide as 'for research only'. These products are not part of an approved study program — purity, dosage and sterility are not vetted under pharmaceutical law.
Medical supervision
As with all compounds in this class, qualified medical supervision is mandatory: blood pressure, pulse, blood glucose, pancreatic enzymes and kidney function must be monitored.
Approved alternatives
Approved alternatives with a comparable mechanism: Semaglutide (Wegovy/Ozempic) and Tirzepatide (Mounjaro/Zepbound) — prescription-only, under medical supervision.
Treatment available
Request a personal consultation
We offer this treatment – free initial consultation.